PROM1 and neoplasm: Obviously, additional studies are needed to address these important questions and will include a comprehensive assessment of tumor phenotype immediately after doxycycline administration, as well as an assessment of the fate of the BTIC population (CD133+ cells) in the in vivo model used here.